Determination of glutathione S-transferase μ and τ polymorphisms in neurological disease

Abstract

1 Correlations between deletions in two glutathione S-transferase (GST) genes, GSTM1 and GSTT1 and susceptibility to Alzheimer's disease (AD), motor neuron disease (MND) and Parkinson's disease (PD) have been investigated by PCR, using primers specific for both genes.

2 It was found that males with a deletion of the GSTM1 gene were more susceptible to PD and males with a deletion of the GSTT1 gene more susceptible to MND and PD, possibly implying that environmental factors which specifically target men may be involved. Furthermore, subjects with a deletion of the GSTT1 gene were more susceptible to AD.

Keywords

glutathione S-transferase GSTM1 GSTT1 allele specific PCR Parkinson's disease Alzheimer's disease motor neuron disease

References

Haradam S , Abei M. Human glutathione S-transferase. In: Pharmacogenetics of drug metabolism. Permagon Press Inc: New York , 1992: pp. 249-259.

Coles B. Effects of modifying structure in electrophilic reactions with biological nucleophiles . Drug Metabolism Reviews 1984; 15: 1307-1334 .

Hussey AJ , Hayes JD. Human Mu-class glutathione S-transferases present in liver, skeletal muscle and testicular tissue . Biochim Biophys Acta 1993; 1203: 131-141 .

Strange RC et al. The human glutathione S-transferases: comparison of isoenzyme expression in normal and astrocytome brain . Biochim Biophys Acta 1992; 1139: 222-228 .

Seidegård J , Vorachek WR , Pero RW , Pearson WR. Hereditary differences in the expression of the human glutathione S-transferase activate on trans-stilbene oxide are due to a gene deletion . Proc Natl Acad Sci 1988; 85: 7293-7297 .

Van Poppel G , de Vogel N , van Bladeren PJ , Kok FJ. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme m . Carcinogen 1992; 13: 303-305 .

Harada S et al. Detection of GST1 gene deletion by polymerase chain reaction and its possible correlation with stomach cancer in Japanese . Hum Genet 1992; 90: 62-64 .

Meyer JD et al. Theta, anewclassofglutathione S-transferases purified from rat and human . J Biochem 1991; 274: 409-414 .

Pemble S et al. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism . J Biochem 1994; 300: 271-276 .

10.

Webb G , Vaska V , Coggan M , Board P. Chromosomal localisation for the human theta class glutathione transferase (GSTT1) . Genomics 1996; 33: 121-123 .

11.

Nelson HH et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta . Carcinogen 1995; 16: 1243-1245 .

12.

Ploemen JHTM et al. Polymorphism in the glutathione conjugation activity of human erythrocytes towards ethylene dibromide and 1,2- epoxy-3-(p-nitrophenoxy)-propane . Biochim Biophys Acta 1995; 1243: 469-476 .

13.

Brockmöller J et al. Genotype and phenotype of glutathione S-transferase class m isoenzymes m and c in lung cancer patients and controls . Cancer Res 1993; 53: 1004-1011 .

14.

Chen J et al. Increased risk for myelodysplastic syndrome in individuals with glutathione transferase theta 1 (GSTT1) gene defect . Lancet 1996; 347: 295-297 .

15.

Steventon GB , Waring RH , Williams AC. Xenobiotic metabolism in Parkinson's disease . Neurology 1989; 39: 883-887 .

16.

Steventon GB et al. Metabolism of low-dose paracetamol in patients with chronic neurological diseases . Neurology 1990; 20: 117-122 .

17.

Steventon GB et al. Xenobiotic metabolism in Alzheimer's disease . Neurology 1990; 40: 1095-1098 .

18.

Heafield MT et al. Plasma cysteine and sulphate levels in patients with motor neuron, Parkinson's and Alzheimer's disease . Neurosci Lett 1990; 110: 216-220 .

19.

Waring RH , Sturman SG , Smith MCG , Steventon GB. S-Methylation in motor neuron disease and Parkinson's disease . Lancet 1989; ii: 356-357 .

20.

Peters L et al. D-Penicillamine metabolism in neurodegenerative diseases an in vivo-in vitro sulphydryl methylation study . Xenobiotics 1994; 24: 1013-1020 .

21.

Stroombergen MCMJ , Waring RH , Bennett P , Williams AC. Determination of the GSTM1 gene deletion frequency in Parkinson's disease by allele specific PCR . Parkinsonism and related disorders 1996; 2: 151-154 .

22.

Smith CAD et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease . Lancet 1992; 339: 1375-1377 .

23.

Katoh T , Inatomi H , Nagaoka A , Sugita A. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients . Carcinogen 1995; 16: 655-657 .

24.

Mulders TMT , Keizer HJ , Breimer DD , Mulder GJ. In vivo characterisation and modulation of the glutathione/glutathione S-transferase system in cancer patients . Drug Metabolism Reviews 1995; 27: 191-229 .

25.

Fryer AA et al. Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 AB, GSTM1 null locus polymorphisms at the glutathione S-transferase, GSTM1 locus . J Biochem 1993; 295: 313-315 .

26.

Strange RC et al. The human glutathione S-transferases: a case-control study on the incidence of the GST1 0 phenotypes in patients with adenocarcinoma . Carcinogen 1991; 12: 25-28 .

27.

Hirvonen A , Husgavel-Pursianen K , Antilla S , Vanio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung . Carcinogen 1993; 14: 1479-1481 .

28.

Lin HJ et al. Ethnic distribution of the glutathione S-transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility . Carcinogen 1994; 15: 1077-1081 .

29.

Zhong S et al. Glutathione S-transferase mu locus: use of genotyping and phenotyping to assess association with lung cancer susceptibility . Carcinogen 1991; 12: 1533-1537 .

30.

Hayes JD , Pulford DJ. The glutathione S-transferase supergene family regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance . Crit Rev Biochem Molec Biol 1995; 30: 445-600 .

31.

Shinka T et al. Relationship between glutathione S-transferase M1 deficiency and urothelial cancer in dye water exposed aromatic amines . JUrol 1998; 159: 380-383 .

32.

Clapper ML et al. Chemopreventive activity of Oltipraz against N-nitrosobis (2-oxopropyl) amine (BOP)-induced ductal pancreatic carcinoma development and effects in survival of Syrian golden hamsters . Carcinogen 1995; 16: 2159-2165 .

33.

Huber WW et al. Chemoprotection against the formation of colon adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (Ph1P) in the rat . Mutat Res 1997; 376: 115-122 .

34.

Agostinelli E , Przybytkowski E , Averill-Bates DA. Glucose, glutathione and cellular responses to spermine oxidation products . Free Rad Biol Med 1996; 20: 649-656 .

35.

Kotake Y et al. 1-Benzyl-1,2,3,4- tetrahydroisoquinoline as a Parkinsonism-inducing agent; a novel endogenous amine in mouse brain and Parkinsonism CSF . J Neurochem 1995; 65: 2633-2638 .

36.

Singer TP , Castagnoli N , Ramsay RR , Trevor AJ. Biochemical events in the development of Parkinsonism induced by 1-methyl-4-phenyl- 1,2,3,6-tetrahydro pyridine . J Neurochem 1987; 49: 1-8 .

37.

Singhal SS et al. Glutathione S-transferases of the human skin: qualitative and quantitative differences in men and women . Biochim Biophys Acta 1993; 1163: 266-272 .

38.

Singhal SS et al. Gender related differences in the expression and characteristics of glutathione S-transferases in human colon . Biochim Biophys Acta 1992; 1171: 19-26 .

39.

Krishna NSR et al. Age related and gender related trends in the expression of glutathione S-transferases in human nasal-mucosa . Annals of Otology, Rhinology and Larynology 1995; 104: 812-822 .

40.

Das M , Dixit R , Seth PK , Mukhtar H. Glutathione S-transferase activity in the brain: species, sex, regional and age differences . J Neurochem 1981; 36: 1439-1442 .